A phase 3, multi-center, randomized withdrawal and long-term extension study of ampreloxetine for the treatment of symptomatic neurogenic orthostatic…
Interventional, randomized, double-blind, placebo-controlled, optional open-label extension trial of LU AF82422 in participants with multiple system…
What is the aim of this study?We are recruiting families with children aged 8 to 11 years old to help us learn about children’s screen use and sleep…
This is an observational study that involves one-time blood draw and data collection.This study aims to identify novel type 1 diabetes biomarkers and…